Thursday, 24 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14475
Articles
Company
Drug
Kira Pharmaceuticals Gains NMPA and TGA Approvals for KP104 Phase II Study
January 27, 2025
Company
Deals
TowardPi Raises RMB 300 Million in Series C Financing Round
January 27, 2025
Company
Drug
Aosaikang Receives FDA Approval for ASKG915 Clinical Trial
January 27, 2025
Company
Deals
Pfizer Exercises Option for Sisunatovir Rights with LianBio
January 27, 2025
Company
Deals
Fosun Pharma Registers Comirnaty Vaccines in Hong Kong
January 27, 2025
Company
Deals
XtalPi Partners with Singapore’s EDDC to Develop Lung Cancer Treatments
January 27, 2025
Deals
Prenetics Acquires Majority Stake in ACT Genomics to Boost Oncology Services
January 27, 2025
Company
Drug
CStone’s Sugemalimab MAA Accepted by UK MHRA for NSCLC Treatment
January 27, 2025
Company
Drug
Ascletis Pharma Receives USPTO Notice for ASC10 Patent
January 27, 2025
Company
Drug
HutchMed Initiates Rolling NDA Submission for Elunate to US FDA
January 27, 2025
Legal / IP
Policy / Regulatory
PCAOB Report Signals Relief for US-Listed Chinese Biotechs
January 27, 2025
Company
Deals
Luye Pharma’s Shandong Boan Biotechnology IPOs on Hong Kong Stock Exchange
January 27, 2025
1
2
…
1,071
1,072
1,073
1,074
1,075
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?